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Abstract. Various structural components of biological membranes are asymmetrically
localized in the two surfaces of the membrane bilayer. This asymmetry is absolute for 
membrane (glyco) proteins, but only a partial asymmetry has been observed for membrane 
phospholipids. In the red cell membrane, choline-phospholipids are localized mainly in the 
outer monolayer whereas aminophospholipids are distributed almost exclusively in the inner 
monolayer. Several evidences are now available to suggest that this distribution of membrane 
phospholipids in red cells is directly or indirectly maintained by the membrane-associated 
cytoskeleton (membrane skeleton). This belief is well supported by the previous as well as 
recent studies carried out in the authors laboratory. Previously, it has been shown that lipid- 
lipid interactions play no major role in maintaining the transmembrane phospholipid 
asymmetry in erythrocytes, and that the asymmetry is lost upon covalent crosslinking of the 
major membrane skeletal protein, spectrin. The recent data presented here further shows that 
degradation or denaturation of spectrin indices rapid transbilayer movement of membrane 
phospholipids in the cells which, in turn, leads to more random phospholipid distributions 
across the membrane. These studies taken together strongly suggest that the skeleton- 
membrane associations are the major determinants of the transmembrane phospholipid
asymmetry in erythrocytes, and that the dissociation of the skeleton from the membrane
bilayer probably results in generation of new reorientation sites for phospholipids in the 
membrane. 
 
Keywords. Cytoskeleton; membrane bilayer; phospholipid asymmetry; phospholipases; 
erythrocytes. 
 
Introduction 
 
It is now commonly believed that the cell cytoskeleton, by virtue of its interactions with 
the plasma membrane, not only regulates the membrane function but also controls the 
membrane structure. Several dynamic processes like cell motility, cell-cell interactions,
membrane deformability, endocytosis, lateral diffusibility of membrane integral 
proteins, etc., seem to be governed by the cytoskeleton-membrane interactions
(reviewed by Geiger, 1983). Amongst the various types of cells studied so far, the red cell 
cytoskeleton and its membrane associations is the best characterized system (for 
reviews see: Haest, 1982; Cohen, 1983; Marchesi, 1983; Sheetz, 1983). 
The red cell membrane is composed of two structural units, viz. the membrane 
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bilayer and the reticulate structure of membrane peripheral proteins, called membrane 
skeleton. The membrane bilayer alone has very little mechanical strength and 
fragments readily by vesiculation. The membrane skeleton associates with the 
cytoplasmic face of the bilayer, and this association provides mechanical stability to the 
membrane and also regulates the membrane structure and function (Sheetz, 1983). The 
skeleton is composed of three major (spectrin, actin and polypeptide 4·1) and possibly 
several minor proteins which specifically interact to form a reticulate type of structure 
(Cohen, 1983). Of the three major proteins, spectrin (Bands 1 and 2) alone accounts for 
about 75% of the total skeletal protein mass (Marchesi, 1983). 
The skeletal network associates with the membrane bilayer primarily via 
protein–protein interactions (Cohen, 1983; Anderson and Lovrein, 1984). This 
association seems to be further stabilized by the interactions of the inner layer 
phospholipids with the underlying skeleton (Haest, 1982). The skeleton-membrane 
interactions not only control the lateral diffusion of membrane integral proteins 
(Sheetz, 1983), but also appear to maintain the asymmetric transmembrane organiz- 
ation of phospholipids in the erythrocytes (Haest et al., 1978; Lubin et al., 1981; Gupta 
et al., 1982; Kumar and Gupta, 1983; Schwartz et al., 1984; Kumar and Gupta, 1984). 
The work presented here clearly shows that on dissociating the skeleton from the 
membrane bilayer, by inducing structural changes in the skeletal components, results 
in the rapid transbilayer movements of phospholipids in the intact cells. This in turn 
leads to more random phospholipid distribution across the membrane. 
 
Experimental procedures 
 
Role of the membrane skeleton in the maintenance of the transmembrane phospholipid 
organization was ascertained by analysing the transbilayer phospholipid distributions 
in the red cells that possessed abnormalities in their skeleton. These cells include both 
pathologic erythrocytes and the red cells in which defined skeletal defects were induced 
in vitro. The pathologic erythrocytes studied were the red cells of humans suffering 
from chronic myeloid leukaemia (CML erythrocytes) as well as the rhesus monkey red 
cells harbouring schizont stage of the malarial parasite, P. knowlesi. Detailed 
procedures for isolation and purification of these cells and their membranes have
already been published elsewhere (Gupta and Mishra, 1981; Kumar and Gupta, 1983). 
Membranes of these cells were routinely analysed for their protein compositions 
by sodium dodecyl sulphate (SDS)-polyacrylamide gel electrophoresis (Fairbanks 
et al., 1971). 
Skeletal defects in the monkey red cells were induced in vitro by subjecting these cells 
to brief heat treatments at the helix-coil transition temperature of spectrin (Brandts et 
al., 1977). The heating was carried out essentially according to Palek et al. (1981). The 
extent of spectrin denaturation was determined by circular dichroism (CD). Spectrin 
samples for the CD measurements were prepared as described by Smith and Palek 
(1983). 
The methods that are currently in use for studying the transmembrane phospholipid 
organization can be classified into four general categories: (i) enzymatic hydrolysis, 
(ii) chemical labelling, (iii) immunochemical labelling, and (iv) biophysical techniques 
(reviewed by Etemadi, 1980). Amongst these, enzymatic (e.g., phospholipase A2 and 
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sphingomyelinase) and chemical (e.g., trinitrobenzene sulphonic acid (TNBS) and 
fluorescamine) probes have been most commonly used (reviewed by Roelofsen, 1982). 
The essential requirements during the use of these probes in such studies are that the 
chemical reagents/enzymes must not permeate across the membrane, and that they 
should completely label/hydrolyse the external phospholipids without affecting the cell 
integrity. Keeping in view these requirements, we have optimised the conditions for 
using phospholipase A2, from various sources, and TNBS to probe the membrane 
phospholipid organization. Experimental procedures in detail have been described 
previously (Gupta and Mishra, 1981; Gupta et al., 1982; Kumar and Gupta, 1983,1984). 
 
 
Results 
 
Membrane phospholipid organization in red cells having cross-linked spectrin 
 
In our earlier studies (Kumar and Gupta, 1983), we have shown that CML erythrocyte 
spectrin is crosslinked via disulphide bonds. This abnormality in these cells was 
associated with loss of the transmembrane phospholipid asymmetry, as analysed by 
phospholipase A2. The latter observation has now been further confirmed by 
employing the chemical probe, TNBS. Table 1 shows that unlike the normal human red 
cells, TNBS labelled both phosphatidylethanolamine (PE) and phosphatidylserine (PS) 
in the CML erythrocytes. To ensure that the labelling of PS in the CML cells did not 
result due to permeation of the probe across the membrane (Haest et al., 1981), the red 
cell anion channel was blocked by the anion channel protein inhibitor, 5,5'-dithio bis(2- 
nitrobenzoic acid) (DTNB) (Reithmeier, 1983). 
 
 
Table 1. Human red cell aminophospholipid label- 
ling with TNBS at 6 h (20°C). 
 
a Labelling was carried out in the presence of the red 
cell anion channel protein inhibitor, DTNB 
(Reithmeier, 1983)·Values are mean of 4–6 determi- 
nations ± S·D· 
 
 
Membrane phospholipid organization in red cells having degraded spectrin 
 
Intracellular malarial parasite is well known to cause extensive degradation of the red 
cell spectrin during the schizont stage of its development (Weidekamm et al., 1973; 
Wallach and Conley, 1977; Gruenberg and Sherman, 1983). Therefore, we decided to 
examine the effect of spectrin degradation on the transbilayer distributions of 
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phosphatidylcholine (PC), PE and PS in the membranes of rhesus monkey red cells that 
were infected with the mature schizont stage of the simian malarial parasite, P. knowlesi, 
using pancreatic phospholipase A2 as the external membrane probe. Table 2 shows that 
unlike the normal uninfected monkey red cells, this enzyme readily hydrolysed about 
40% PE and 47% PS in the infected cells. This indicates that degradation of spectrin in 
the intact red cells induces marked reorganization of membrane phospholipids in the 
two surfaces of the membrane bilayer. 
 
 
Table 2. Red cell phospholipid degradation by phospho-
lipase A a
2
 at 1 h. 
 
a From porcine pancreas. Values are mean of 12–16 determi- 
nations ± S.D. 
 
 
Membrane phospholipid organization in red cells having denatured spectrin
 
Previous studies have demonstrated that heating of the human red cells at 48–51°C 
results in thermal denaturation of spectrin (Brandts et al., 1977) and fragmentation of 
the cells into spherocytes and exocytotic vesicles (Ham et al., 1948). Therefore, we 
heated the monkey red cells at 47°C, 49°C and 51°C. The effect of the heat treatment on 
the red cell shape was examined by light microscopy. This treatment at 49°C for 15 min 
led to the formation of micro vesicles and consequently the transformation of the cell 
shape from diskocytes to spherocytes (data not shown). No such effect on the integrity 
of the membrane was observed upon heating the cells under identical conditions at 
47°C. On the contrary, extensive hemolysis of the cells occurred when the heating 
temperature was raised to 51oC. To confirm that heating of the monkey red cells at 
49–50°C results in irreversible thermal denaturation of spectrin, we determined the
apparent helical content of spectrin, both before and after heating, using C.D. Table 3 
 
 
Table 3. Denaturation of spectrin- 
on heating at 49–50°C. 
 
a Determined by C.D. 
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shows that 28–30% of the total helical content of monkey red cell spectrin was lost 
upon heating at 49–50°C for 15 min. However, this treatment in identical conditions for 
10 min and 5 min appeared to result in only 20–25% and 5–8% loss of the apparent 
helicity respectively. It may, therefore, be concluded that the heating of red cells at 
49–50°C leads to unfolding of spectrin. 
Effect of spectrin denaturation on the transmembrane phospholipid organization in 
the red cells was analysed using phospholipase A2, from two different sources, as the 
external membrane probe. Table 4 shows that both bee venom phospholipase A2 and 
pancreatic phospholipase A2 hydrolysed greater amounts of membrane phospholipids 
in the heat-treated cells than in normal cells. In the normal cells, only PC and PE were 
accessible to bee venom phospholipase A2. But this enzyme in the heated cells also 
degraded PS. That a fraction of PS from the inner monolayer has moved to the outer 
monolayer in the heated cells was further confirmed by employing pancreatic 
phospholipase A2 as the enzymatic probe (Roelofsen, 1982). Unlike the normal red 
cells, this enzyme readily hydrolysed PC, PE and PS in the heat-treated cells (table 4). 
These results demonstrate that denaturation of spectrin induces loss of membrane 
phospholipid asymmetry in erythrocytes. 
 
 
Table 4. Monkey red cell phospholipid hydrolysis by phospholipase A2 at 1 h. 
 
Values are mean of 4–6 determinations ± S.D. 
 
 
Discussion 
 
In the red cell membrane, the choline-phospholipids localize mainly in the outer 
monolayer whereas the aminophospholipids distribute almost exclusively in the inner 
monolayer (Op den Kamp, 1979). It is, however, not yet clear as to how this asymmetric 
distribution of the membrane phospholipids is generated and maintained in the cells. 
Our previous studies have shown that lipid–lipid interactions play no major role in the 
maintenance of the membrane phospholipid asymmetry, and suggested that it probably 
originates from differential interactions between phospholipids and membrane 
proteins, especially skeletal proteins (Kumar and Gupta, 1984). This suggestion is well 
supported by the finding that covalent crosslinking of the red cell spectrin is invariably 
associated with loss of the transmembrane phospholipid asymmetry (Haest et al., 1978; 
Gupta et al., 1982; Kumar and Gupta, 1983). Also, random distributions of PS have 
been observed in the red cells that lack polypeptide 4.1, another major skeletal protein
(Schwartz et al., 1984). Moreover, absence of the membrane phospholipid asymmetry 
has been witnessed in the red cells which have deformed membrane skeleton (Lubin
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et al., 1981). Furthermore, our present studies clearly demonstrate that covalent 
crosslinking or degradation or denaturation of spectrin in intact red cells results in 
more random distributions of membrane phospholipids in the two surfaces of the 
membrane bilayer. These observations put together provide sufficient evidence to the 
belief that the membrane skeleton directly or indirectly controls the asymmetric 
organization of membrane phospholipids in the red cells. 
Degradation, denaturation or genetic deficiency of one or more skeletal proteins in 
red cells must result in either disruption or destabilization of the skeletal network. On 
the other hand, covalent crosslinking of skeletal proteins would tend to rigidify the 
skeleton, which in turn will affect the skeletal dynamics (Sheetz, 1983). In either of these 
cases, the skeleton-membrane associations should be modified. That these associations 
stabilize the red cell membrane phospholipid asymmetry is further supported by the 
finding that the transmembrane phospholipid distributions in red cells are altered 
during drug-induced endocytosis (Schrier et al., 1983). 
Several studies have shown that skeletal defects in red cells induce rapid transbilayer 
movements of phospholipids in the membrane (Mohandas et al., 1982; Franck et al., 
1982, 1983; Bergmann et al., 1984a). This is quite consistent with our observations that
various structural alterations in spectrin lead to migration of PS to the outer surface. To 
examine whether the rate of these movements is related to the extent of structural 
changes introduced in the skeleton, we have studied the kinetics of membrane 
phospholipid hydrolysis in the red cells that received heat treatments for varying 
periods of time. Figure 1 shows that the amounts of hydrolysed phospholipids in the 
15 min and 10 min heat-treated cells (B and C) did not significantly increase with time. 
But in the 5 min heated cells the hydrolysis of PE and PS increased with time upto 4 h 
after which it virtually remained constant at least upto 12 h (D, figure 1). These 
observations clearly show that extensive structural changes in spectrin lead to almost 
spontaneous transbilayer movements of PE and PS from the inner monolayer to the 
outer monolayer, however, these movements are relatively slow in case a very limited 
fraction of the cell spectrin is altered. 
Transbilayer phospholipid movement in the normal red cells is a very slow process 
(van Meer and Op den Kamp, 1982). Acceleration of this process in the cells having 
altered membrane skeleton should, therefore, arise from some specific membrane 
changes which facilitate the transbilayer mobility of phospholipids in the membrane. 
We propose that these membrane changes result in generation of new reorientation
sites for phospholipids in the cells. The number of these sites seems to be governed by 
the extent of the dissociation between skeleton and the bilayer, as suggested by our 
finding that transmembrane phospholipid mobility in the 15 min heat-treated red cells 
was considerably faster than in the 5 min heated cells. This contention is further 
supported by the studies of Dressier et al. (1984) wherein it has been shown that the 
extent of spectrin crosslinking in the diamide-treated red cells is in direct correlation to 
the rate of transbilayer movements of exogenous phospholipids. 
From these discussions, it would appear that the membrane phospholipid asym- 
metry is stabilized by the skeletal control of reorientation sites for phospholipids in the 
membrane. But recent studies of Bergmann et al. (1984b) have demonstrated that 
exogenous lyso PS inserted in the outer monolayer of the red cells almost spon- 
taneously concentrates in the inner monolayer, whereas lyso PC prefers the outer
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Figure 1. Kinetics of hydrolysis of erythrocyte phospholipids by phospholipase A2. A, 
normal erythrocytes; Β, 15 min heat-treated erythrocytes; C, 10 min heat-treated erythrocytes; 
D, 5 min heat-treated erythrocytes. Heat treatment was carried out at 49–50°C. In A–C, red 
cells were hydrolysed by bee venom phospholipase A2 while in D, phospholipase A2 from 
porcine pancreas was used. (?), PC; (O), PE; (∆), PS. 
 
monolayer. This suggests that the asymmetric distribution of PS in the native red cell 
membrane does not result from a lack of transbilayer mobility but seems to be a 
consequence of interactions between PS and skeletal proteins. Although no direct 
demonstration of these interactions has yet been made in the native erythrocyte 
membrane, but spectrin and polypeptide 4·1 have been shown to interact preferentially 
with PS in mixed phospholipid vesicles and monolayers (Mombers et al., 1979, 
1980; Sato and Ohnishi, 1983; Bonnet and Begard, 1984). Additionally, it is known that 
the interactions between spectrin and PS are strengthened by the presence of PE in the 
lipid mixture (Mombers et al., 1979). 
Finally, it may be concluded that asymmetric transmembrane phospholipid
organization in red cells is primarily maintained by the skeleton-membrane associ- 
ations. As the asymmetric assembly of membrane phospholipids has already been 
established in various cell types (Op dem Kamp, 1979), it may be envisaged that this 
asymmetry in other cells is also maintained by similar mechanisms. This speculation
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seems all the more plausible, since proteins similar to red cell skeletal proteins have been 
identified in the membrane-associated cytoskeleton of a variety of cells (Geiger, 1983; 
Cohen, 1983; Glenney and Glenney, 1983). 
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